- Statement of Commissioner Alvaro M. Bedoya Regarding the Commission's Policy Statement on Rebates and Fees in Exchange for Excluding Lower-Cost Drug Products ( )
- Remarks of Chair Lina M. Khan Regarding Policy Statement on Rebates and Fees in Exchange for Excluding Lower-Cost Drug Products ( )
- Policy Statement of the Â鶹´«Ã½ Trade Commission on Rebates and Fees in Exchange for Excluding Lower Cost Drug Products ( )
- Statement of Chair Lina M. Khan Regarding 6(b) Study of Pharmacy Benefit Managers ( )
- Statement of Commissioner Rebecca Kelly Slaughter Regarding 6(b) Study of Pharmacy Benefit Managers ( )
- Concurring Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding 6(b) Study of Pharmacy Benefit Managers ( )
- Concurring Statement of Commissioner Slaughter and Chair Khan regarding FTC and State of Rhode Island v. Lifespan Corporation and Care New England Health System ( )
- Concurring Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding Lifespan Corporation and Care New England Health System ( )
- Stopping COVID-19 Fraud and Price Gouging ( )
- Statement of Chair Lina M. Khan on the Ruling by Judge Denise L. Cote Regarding Â鶹´«Ã½ Trade Commission et al v. Vyera Pharmaceuticals, LLC et al Regarding ( )
- Dissenting Remarks of Commissioner Noah Joshua Phillips Regarding the Commission's Issuance of Seven Omnibus Resolution ( )
- Dissenting Statement of Commissioner Christine S. Wilson ( )
- Statement of Commissioner Rohit Chopra regarding the Review of the FTC's Pharmaceutical Merger Â鶹´«Ã½ Program ( )
- Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson regarding the Multilateral Pharmaceutical Merger Task Force ( )
- Prepared Statement of the Â鶹´«Ã½ Trade Commission: Curbing COVID Cons: Warning Consumers about Pandemic Frauds, Scams, and Swindles ( )
- Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding the Commission’s Advocacy to the Department of Veterans Affairs ( )
- Dissenting Statement of Commissioner Rebecca Kelly Slaughter Regarding the FTC Staff Comment on the VA's Interim Final Rule on the Authority of VA Professionals to Practice Health Care ( )
- Dissenting Statement of Commissioner Rohit Chopra Regarding the Commission's Advocacy to the Department of Veterans Affairs ( )
- Separate Statement of Commissioner Noah Joshua Phillips In the Matter of Flo Health, Inc. ( )
- Joint Statement of Commissioner Rohit Chopra and Commissioner Rebecca Kelly Slaughter Concurring in Part, Dissenting in Part, In the Matter of Flo Health, Inc. ( )
- Concurring Statement of Commissioner Christine S. Wilson Regarding the CBD Â鶹´«Ã½ Actions ( )
- Statement of Commissioner Rohit Chopra Regarding CBD Â鶹´«Ã½ Actions ( )
- Statement of Commissioner Christine S. Wilson, Joined by Commissioner Noah Joshua Phillips, In the Matter of Methodist Le Bonheur Healthcare ( )
- Statement of Commissioner Rohit Chopra in the Matter of Stryker and Wright Medical ( )
- Dissenting Statement of Commissioner Rohit Chopra Joined by Commissioner Rebecca Kelly Slaughter in the Matter of Pfizer Inc./Mylan N.V. ( )
- Statement of Commissioner Christine S. Wilson in the Matter of Pfizer Inc./Mylan N.V. ( )
- Statement of Commissioner Rohit Chopra Regarding the Report to Congress on Protecting Older Consumers ( )
- Statement of Commissioner Rebecca Kelly Slaughter Concerning the Contact Lens Rule ( )
- Occupational Licensing in Health Care: Sorting the Wheat from the Chaff ( )
- Wilson says pandemic underscores need to establish privacy rules for 'Big Tech' ( )
The .gov means it’s official.
Â鶹´«Ã½ government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.